Benutzer: Gast  Login
Titel:

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration wit

Dokumenttyp:
Journal Article; Research Support, Non-U.S. Gov't; Article
Autor(en):
Maier, S; Nimmrich, I; Koenig, T; Eppenberger-Castori, S; Bohlmann, I; Paradiso, A; Spyratos, F; Thomssen, C; Mueller, V; Nährig, J; Schittulli, F; Kates, R; Lesche, R; Schwope, I; Kluth, A; Marx, A; Martens, JW; Foekens, JA; Schmitt, M; Harbeck, N
Abstract:
Our aim was to identify and validate DNA-methylation markers associated with very good outcome in node negative, hormone receptor positive breast cancer patients after adjuvant endocrine therapy which might allow identifying patients who could be spared the burden of adjuvant chemotherapy. Using a methylation microarray, we analysed 117 candidate genes in hormone receptor-positive tumours from 109 breast cancer patients treated by adjuvant tamoxifen. Results were validated in an independent coho...     »
Zeitschriftentitel:
Eur J Cancer
Jahr:
2007
Band / Volume:
43
Heft / Issue:
11
Seitenangaben Beitrag:
1679-86
Sprache:
eng
Volltext / DOI:
doi:10.1016/j.ejca.2007.04.025
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/17601725
Print-ISSN:
0959-8049
TUM Einrichtung:
Frauenklinik und Poliklinik; Institut für Allgemeine Pathologie und Pathologische Anatomie
 BibTeX